Jun 06, 2019 / 07:00PM GMT
David Howard Windley - Jefferies LLC, Research Division - Equity Analyst
All right. Good afternoon. Hello, everybody. I'm Dave Windley with Jefferies Healthcare Equity Research. Thank you for being here at our 2019 Global Healthcare Conference in New York. Our next presenting company is Catalent, ticker CTLT. Here to talk to us about Catalent -- we're going to do a little fireside chat here, but here with me on the stage is Wetteny Joseph, the company's Chief Financial Officer; and Tom Castellano, the company's VP of Finance. He's got multiple hats: VP of Finance, IR, Treasurer. So thank you both to you guys for being here.
So Wetteny, just to start, we, I think, know that Catalent is a CDMO, but it has been kind of transforming itself through number of transactions over the last couple of years. Why don't you kind of layout that transformation for us?
Wetteny N. Joseph - Catalent, Inc. - Senior VP & CFO
Yes, sure. So for those of you who are new to the Catalent name, we are the leader in advanced delivery dosage forms and development solutions. Our
Catalent Inc at Jefferies Healthcare Conference Transcript
Jun 07, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers